Review of Applications of Near-Infrared Spectroscopy in Two Rare Disorders with Executive and Neurological Dysfunction: UCD and PKU
Open Access
Abstract
Studying rare diseases, particularly those with neurological dysfunction, is a challenge to researchers and healthcare professionals due to their complexity and small population with geographical dispersion. Universal and standardized biomarkers generated by tools such as functional neuroimaging have been forged to collect baseline data as well as treatment effects. However, the cost and heavily infrastructural requirement of those technologies have substantially limited their availability. Thus, developing non-invasive, portable, and inexpensive modalities has become a major focus for both researchers and clinicians. When considering neurological disorders and diseases with executive dysfunction, EEG is the most convenient tool to obtain biomarkers which can correlate the objective severity and clinical observation of these conditions. However, studies have also shown that EEG biomarkers and clinical observations alone are not sensitive enough since not all the patients present classical phenotypical features or EEG evidence of dysfunction. This article reviews disorders, including two rare disorders with neurological dysfunction and the usefulness of functional near-infrared spectroscopy (fNIRS) as a non-invasive optical modality to obtain hemodynamic biomarkers of diseases and for screening and monitoring the disease.Keywords
Funding Information
- O’Malley Family Foundation
- NIH (U54HD061221)
- NIH NIGMS Postdoctoral Fellowship in Medical Genetics (5T32GM007454)
This publication has 52 references indexed in Scilit:
- Autoregressive model based algorithm for correcting motion and serially correlated errors in fNIRSBiomedical Optics Express, 2013
- Quantification of the cortical contribution to the NIRS signal over the motor cortex using concurrent NIRS-fMRI measurementsNeuroImage, 2012
- N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatmentThe Application of Clinical Genetics, 2011
- Disruption of prefrontal function and connectivity in individuals with phenylketonuria☆Molecular Genetics and Metabolism, 2010
- Measuring in vivo ureagenesis with stable isotopesMolecular Genetics and Metabolism, 2010
- Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders ConsortiumMolecular Genetics and Metabolism, 2010
- N-carbamylglutamate Markedly Enhances Ureagenesis in N-acetylglutamate Deficiency and Propionic Acidemia as Measured by Isotopic Incorporation and Blood BiomarkersPediatric Research, 2008
- Testing for Nonlinearity in Functional Near-Infrared Spectroscopy of Brain Activities by Surrogate Data MethodsThe Journal of Physiological Sciences, 2008
- Neurological implications of urea cycle disordersJournal of Inherited Metabolic Disease, 2007
- Deficits in memory strategy use related to prefrontal dysfunction during early development: Evidence from children with phenylketonuria.Neuropsychology, 2001